"what is big pharma waiting on ??".....
Well, now we know it's about Cytodyn not giving away Leromlimab's upregulating.
Upregulating is cornerstone to creating new markets that will be larger than current ones
We'll partner -- just not A- typical
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-
